insulin measurements are not advised for cardiometabolic risk screening in large groups. Here we assessed the accuracy of the single-point insulin sensitivity estimator (SpiSe) to diagnose cardiometabolic risk in Chilean adolescents. In 678 post-pubertal adolescents (52% males, M(SD) age = 16.8 (0.2) years), height, weight, waist circumference, blood lipids, glucose, insulin, and blood pressure were measured. BMI, HOMA-IR, and SPISE were estimated; HOMA-IR values ≥ 2.6 were considered insulin resistance (IR). Metabolic syndrome (MetS) was defined with the joint IDF/AHA/ nHBLi standard. Using receiver operating characteristic curves, we obtained optimal SpiSe cutpoints for IR and MetS diagnosis. The prevalence of MetS and IR was 8.2% and 17.1%, respectively. In males, the optimal cutoff for MetS diagnosis was 5.0 (sensitivity: 97%; specificity: 82%), and the optimal cutoff for IR diagnosis was 5.9 (sensitivity: 71%; specificity: 83%). In females, a SPISE of 6.0 had the highest sensitivity (90%) and specificity (74%) for MetS diagnosis. A SPISE of 6.4 was the optimal cutoff for IR diagnosis; however, sensitivity and specificity were 61% and 75%. In males and female post-pubertal adolescents, SpiSe had a very good and good diagnostic performance, respectively, in predicting MetS. It was an accurate diagnostic tool for IR prediction in males, but not necessarily in females. Insulin resistance (IR), reduced responsiveness of a target cell or a whole organism to the insulin concentration to which it is exposed, is the prelude of major cardiometabolic disorders, such as coronary heart disease, stroke, Metabolic Syndrome (MetS), non-alcoholic fatty liver disease (NAFLD) and type-2 diabetes (T2D) 1,2. IR may be due to several causes, including the excess of adipose tissue, especially visceral adiposity. In children and adolescents, IR has grown dramatically, closely linked to the obesity epidemic, and the spread of Western-type dietary habits and sedentary behaviors 2,3. In Chile, one in four adolescents between 15 and 19 years of age have obesity, and 14% have MetS 4 , which suggests a rising number of individuals exposed to an early onset of serious and economically burdensome chronic illnesses. Early recognition of insulin-resistant youths may be beneficial for both clinical practice and population-based health promotion efforts. The reference standard to evaluate IR is the hyperinsulinemic-euglycemic clamp; however, it is invasive, costly, and difficult to perform in clinical and epidemiological settings 1. Several surrogate biomarkers have been proposed based on fasting measurements of glucose and/or insulin: HOMA-IR, QUICKI, 1/HOMA, log(HOMA), and 1/insulin 1-3. Pulsatility of insulin release, a relatively short half-life (~ 4-6 min), the fact that insulin assays are poorly standardized and may provide different results on the same sample, and difficulties in handling and storage can all cause problems in insulin determination and interpretation of results 5-7. Thus, insulin measurements are